Dr Agarwals Health Care Ltd (AGARWALEYE)
₹478.90
Mkt cap
₹15,182 Cr
P/E ratio
115.00
P/B
7.49
Div yield
0.00%
ROE
6.81%
ROCE
11.10%
EPS (TTM)
₹4.16
Book value
₹64
52W range
407–546
Sector
Healthcare
Incorporated in 2010, [1] Dr. Agarwal’s Health Care offers a wide array of eye care services, which include cataract and refractive surgeries, consultations, diagnoses, and non-surgical treatments. Additionally, they provide optical products, contact lenses, accessories, and pharmaceutical items related to eye care. [2]
Health check
Cautious
ValuationExpensive
ProfitabilityWeak
GrowthHigh
TechnicalsNeutral
52-week range
−12.24% from high₹479
₹407+17.80% from low₹546
Current
₹478.90
Prev close
₹479.70
Day
−0.17%
Price performance
1D
−0.17%
1W
−1.20%
1M
−1.19%
3M
+9.31%
6M
+1.59%
1Y
+11.39%
YTD
−4.59%
Financials
FRevenue, profit & margin
P/E ratio
115.0×
AGARWALEYE is 139% above the sector median of 48.1×
AGARWALEYE115.0×
Sector median48.1×
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 333 | 349 | 403 | 417 | 431 | 460 | 487 | 499 | 530 | 564 | |
| Expenses | 244 | 241 | 300 | 310 | 316 | 329 | 360 | 363 | 386 | 403 | |
| Operating Profit | 89 | 108 | 104 | 107 | 115 | 131 | 128 | 136 | 144 | 161 | |
| OPM % | 27% | 31% | 26% | 26% | 27% | 28% | 26% | 27% | 27% | 29% | |
| Other Income | 12 | 20 | 6 | 12 | 13 | 13 | 13 | 8 | 11 | 14 | |
| Interest | 22 | 27 | 27 | 28 | 28 | 25 | 25 | 23 | 21 | 22 | |
| Depreciation | 43 | 47 | 56 | 57 | 58 | 60 | 63 | 68 | 69 | 77 | |
| Profit before tax | 36 | 54 | 27 | 33 | 41 | 59 | 54 | 54 | 65 | 77 | |
| Tax % | 37% | 24% | 33% | 36% | 31% | 27% | 29% | 32% | 33% | 35% | |
| Net Profit | 23 | 41 | 18 | 21 | 28 | 43 | 38 | 36 | 44 | 50 | |
| EPS in Rs | 0.72 | 1.03 | 0.95 | 0.94 | 1.07 | 1.25 | |||||
| Raw PDF |
Earnings
EResults dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Avg earnings-day move −1.18% · closed higher next day 2 of last 6
| Q3FY25 | Q4FY25 | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26 | |
|---|---|---|---|---|---|---|
| Broadcast | 15 Feb '25◦ | 29 May '25 | 12 Aug '25◦ | 30 Oct '25◦ | 3 Feb '26◦ | 21 May '26◦ |
| Earnings day | −3.26% | −2.46% | +0.41% | −2.44% | +1.04% | −0.36% |
| +1 day | −5.06% | −3.75% | +4.29% | −0.06% | +2.41% | −0.29% |
| +5 days | −8.31% | +6.01% | +1.26% | −3.04% | +2.71% | +0.05% |
| +15 days | −4.31% | +16.21% | −5.36% | −2.37% | +1.23% | −8.69% |
| +30 days | −0.69% | +23.11% | +8.72% | −4.03% | −4.98% | −1.78% |
| Filing | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL |
Corporate actions
CLast 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
Sas of Jun 202632.34%Promoter
Promoters32.34%
FIIs57.97%0.03
DIIs7.72%0.11
Public1.97%0.10
Ownership trend
Peers
P8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals | ₹8,805.50 | 64.74 | 1,26,610 | 0.23% | 551 | +35.86% | 6,606 | +18.12% | 17.89% |
| Max Healthcare | ₹1,080.40 | 70.88 | 1,05,149 | 0.19% | 342 | +7.28% | 2,143 | +12.21% | 14.71% |
| Fortis Health. | ₹948.70 | 67.78 | 71,623 | 0.11% | 271 | +22.42% | 2,365 | +17.81% | 13.45% |
| Aster DM Health. | ₹785.65 | 167.78 | 68,483 | 0.64% | 154 | +41.97% | 1,182 | +18.20% | 11.40% |
| Narayana Hrudaya | ₹1,961.50 | 47.06 | 40,085 | 0.23% | 224 | +12.47% | 2,594 | +75.80% | 15.36% |
| Global Health | ₹1,371.00 | 66.15 | 36,862 | 0.04% | 142 | +4.71% | 1,159 | +24.46% | 17.14% |
| Krishna Institu. | ₹797.85 | 135.11 | 33,510 | 0.00% | 33 | −50.66% | 1,075 | +34.85% | 9.29% |
| Dr Agarwal's Hea | ₹478.90 | 114.60 | 15,182 | 0.00% | 50 | +14.88% | 564 | +22.57% | 11.12% |
| Median: 28 Co. | ₹421.75 | 48.14 | 5,380 | 0.02% | 31 | +22.42% | 353 | +22.28% | 14.76% |
Filings
DAnnual reports1
Concall transcripts18
Credit ratings6
Announcements5
Announcement under Regulation 30 (LODR)-Newspaper Publication 20 Jul - Newspaper Advertisement of Notice of Hearing of the Company''s Petition in relation to the Scheme of Amalgamation between Dr. Agarwal''s Eye Hospital Limited and Dr. …Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 9 Jul - Allotment of 43,155 Equity Shares pursuant to the exercise of options granted under Dr. Agarwal''s Health Care Limited - Employee Stock Option Scheme 2022.Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 7 Jul - Regulation 74(5) depository compliance certificate filed for quarter ended June 30, 2026.Summary Of The Proceedings Of The Hon''ble NCLT Convened Meeting Of The Secured Creditors Of Dr. Agarwal''s Health Care Limited Held On July 02, 2026 2 Jul - NCLT secured creditors meeting on July 2, 2026 approved amalgamation scheme with Dr. Agarwal's Eye Hospital.Voting Results And The Consolidated Scrutinizer''s Report On The NCLT Convened Meeting Of The Equity Shareholders Of Dr. Agarwal''s Health Care Limited Held On July 02, 2026. 2 Jul - Secured creditors approved Dr. Agarwal’s Eye Hospital amalgamation scheme on July 2, 2026.